Castle Biosciences Inc
CSTL
Market Cap$626.96M
Close$
$33.86
48.2% upside
Current Fair Value
48.2% upsideUndervalued by 48.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $626.96 Million |
|---|---|
| Enterprise Value | $399.17 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.14 |
| Beta | 1.58 |
| Outstanding Shares | 27,449,983 |
| Avg 30 Day Volume | 158,563 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.91 |
|---|---|
| PEG | 12.47 |
| Price to Sales | 2.86 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 1.82 |
| Enterprise Value to EBIT | -5.87 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data